JOSÉ RAMÓN JARABO SARCEDA-rekin lankidetzan egindako argitalpenak (22)

2024

  1. Gut Microbiota Signatures with Potential Clinical Usefulness in Colorectal and Non-Small Cell Lung Cancers

    Biomedicines, Vol. 12, Núm. 3

  2. Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP

    Clinical and Translational Oncology

2023

  1. Implementation of a perioperative care App in elective thoracic surgery

    Cirugia Espanola, Vol. 101, Núm. 4, pp. 265-273

  2. Role of Telomere Length in Survival of Patients with Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases

    Biomedicines, Vol. 11, Núm. 12

  3. The Use of Fissios App© as a Complement to a Face-to-Face Respiratory Physiotherapy Program versus an Attendance-Only Face-to-Face Physiotherapy Program in Patients Scheduled for Thoracic Surgical Procedures Reduces the Risk of Developing Postoperative Pulmonary Complications—A Quasi-Experimental Study

    Journal of Clinical Medicine, Vol. 12, Núm. 21

  4. Tratamiento quirúrgico en cáncer de pulmón

    Revisiones en Cancer, Vol. 37, Núm. 3, pp. 121-132

2022

  1. Preoperative detection and evaluation of the need for psychological intervention in cancer and non-cancer patients referred to thoracic surgery

    Cirugia Espanola, Vol. 100, Núm. 6, pp. 359-366

  2. Thoracic surgery in Spain

    Journal of Thoracic Disease, Vol. 14, Núm. 3, pp. 779-787

2021

  1. Targeted therapy moves to earlier stages of non-small-cell lung cancer: Emerging evidence, controversies and future challenges

    Future Oncology, Vol. 17, Núm. 30, pp. 4011-4025

2020

  1. Recommendations for acting in elective and urgent thoracic surgery during SARS-CoV-2 pandemic. Spanish Society of Thoracic Surgery

    Cirugia Espanola, Vol. 98, Núm. 10, pp. 574-581

2018

  1. Cirugía de las metástasis pulmonares de sarcomas. Racional de la cirugía. Impacto en supervivencia

    Revisiones en Cancer, Vol. 32, Núm. 2, pp. 121-130

  2. Combined Hepatic and Pulmonary Metastasectomies From Colorectal Carcinoma. Data From the Prospective Spanish Registry 2008–2010

    Archivos de Bronconeumologia, Vol. 54, Núm. 4, pp. 189-197

2016

  1. Neumotórax, hemotórax y quilotórax

    Neumología clínica (Elsevier España), pp. 684-692

2015

  1. A 50-gene signature is a novel scoring system for tumor-infiltrating immune cells with strong correlation with clinical outcome of stage I/II non-small cell lung cancer

    Clinical and Translational Oncology, Vol. 17, Núm. 4, pp. 330-338

  2. Telomere length and telomerase activity in non-small cell lung cancer prognosis: clinical usefulness of a specific telomere status

    Journal of Experimental and Clinical Cancer Research, Vol. 34, Núm. 1

2014

  1. Carcinoma broncogénico no microcítico resecado, estadio pIIIA-N2: ¿En qué pacientes la adyuvancia ofrece mayor beneficio?

    Cirugia Espanola, Vol. 92, Núm. 4, pp. 277-282

  2. Poly (ADP-ribose) polymerase 3 (PARP3), a potential repressor of telomerase activity

    Journal of Experimental and Clinical Cancer Research, Vol. 33, Núm. 1

  3. Relationship of immunohistochemical biomarker expression and lymph node involvement in patients undergoing surgical treatment of NSCLC with long-term follow-up

    Tumor Biology, Vol. 35, Núm. 5, pp. 4551-4559

2011

  1. More than one pulmonary resections or combined lung-liver resection in 79 patients with metastatic colorectal carcinoma

    Journal of Surgical Oncology, Vol. 104, Núm. 7, pp. 781-786

2009

  1. Tratamiento quirúrgico del cáncer de pulmón

    Revisiones en Cancer, Vol. 23, Núm. 4, pp. 140-150